← 홈

림프종

650개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 650개
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

CD19-CAR novel oncolytic vaccinia virus (CD19-CAR novel oncolytic vaccinia virus)

Refractory/Relapsed B-cell Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleAffiliated Hospital to Academy …Phase 1

CD19-CAR-NK (CD19-CAR-NK)

Adult Relapsed/Refractory B-cell Hematologic Malignancies · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

CD19-CAR-NK/T (CD19-CAR-NK/T)

Primary Mediastinal B-cell Lymphoma (PMBCL); Mantle Cell Lymphoma (MCL) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

CD19-CART (CD19-CART)

B Acute Lymphoblastic Leukemia; Mantle Cell Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBambino Gesù Hospital and Resea…Phase 2

CD19-CAR_Lenti T cell (CD19-CAR_Lenti T cell)

Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBambino Gesù Hospital and Resea…Phase 1

CD19-CAR_Lenti_ALLO (CD19-CAR_Lenti_ALLO)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

CD19-PD1-CART Cell (CD19-PD1-CART Cell)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleTimmune Biotech Inc.Phase 1

CD19-TriCAR-T (CD19-TriCAR-T)

Non-hodgkin Lymphoma,B Cell · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleSecond Military Medical Univers…Phase 2

CD19-specific chimeric antigen receptor (CD19-specific chimeric antigen receptor)

Recurrent B-Cell Tumor; Refractory B-Cell Tumor · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleFuda Cancer Hospital, GuangzhouPhase 2

CD19-targeting CAR T Cells infusion (CD19-targeting CAR T Cells infusion)

B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleUniversity of Maryland, Baltimo…Phase 1

CD19.20.22 CAR T cells (CD19.20.22 CAR T cells)

B-Cell Lymphoma; Diffuse Large B Cell Lymphoma (DLBCL) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-CD28Z T Cells - dose escalation 1 (CD19.CAR-CD28Z T Cells - dose escalation 1)

Non-Hodgkin's Lymphoma; B-Cell ALL · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-CD28Z T Cells - dose escalation 2 (CD19.CAR-CD28Z T Cells - dose escalation 2)

Non-Hodgkin's Lymphoma; B-Cell ALL · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-aNKT cells (CD19.CAR-aNKT cells)

Refractory B-Cell Non-Hodgkin Lymphoma; Refractory B-Cell Small Lymphocytic Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group A (CD19.CAR-multiVST for Group A)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleBaylor College of MedicinePhase 1

CD19.CAR-multiVST for Group B (CD19.CAR-multiVST for Group B)

Non-hodgkin Lymphoma; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

CD19/22 CART (CD19/22 CART)

Relapsed Non Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleChina Immunotech Pharmaceutical…Phase 1

CD19/CD20 Dual-CAR-T cells (CD19/CD20 Dual-CAR-T cells)

B-cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleHenan Hualong Biotechnology Com…Phase 1

CD19/CD20 bispecific CAR-T cells (CD19/CD20 bispecific CAR-T cells)

B-Cell Lymphoma Stage I; Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstalePeking UniversityPhase 1

CD19/CD20-directed Chimeric Antigen Receptor T Cells (CD19/CD20-directed Chimeric Antigen Receptor T Cells)

B Cell Non-Hodgkin's Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE

20 / 33 페이지

← 이전다음 →